Goldman Sachs’ long term hinges on a lower-profile, substantial-development small business

Goldman Sachs’ long term hinges on a lower-profile, substantial-development small business


Critical Details
  • Goldman faces an inflection place: Boom-or-bust pursuits like buying and selling or advising on mergers have fallen out of favor with investors.
  • Which is why Goldman CEO David Solomon has hitched his fortunes to asset and prosperity management right after dropping an sick-fated retail banking work.
  • Fears surfaced lately after previous asset administration co-head Julian Salisbury departed Goldman for a scaled-down rival. His previous co-head, Luke Sarsfield, also still left before this yr, encouraging gasoline concerns about a mind drain at Goldman.



Resource

Here are 3 forces that drove the stock market during Wall Street’s comeback week
Finance

Here are 3 forces that drove the stock market during Wall Street’s comeback week

The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names like Meta Platforms , Nvidia and Amazon . The tech-heavy index ended the week 1.9% […]

Read More
Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’
Finance

Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’

ETF Edge Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’ Published Sat, Feb 21 202611:00 AM EST Blair Bao WATCH LIVE Source

Read More
Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more
Finance

Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more

Check out the companies making headlines before the bell. Grail — Shares cratered 47% after the company said a trial of one of its drugs missed its primary endpoint and failed to show statistically significant Stage III-IV cancer reduction. Blue Owl Capital — Shares slid nearly 3%, a day after after the private market and […]

Read More